Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

BACKGROUND: Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in pregnant women are limited. We describe outcomes in the first 86 pregnant women with severe COVID-19 who were treated with remdesivir. METHODS: The reported data span 21 March to 16 June 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Burwick, Richard M, Yawetz, Sigal, Stephenson, Kathryn E, Collier, Ai-Ris Y, Sen, Pritha, Blackburn, Brian G, Kojic, E Milunka, Hirshberg, Adi, Suarez, Jose F, Sobieszczyk, Magdalena E, Marks, Kristen M, Mazur, Shawn, Big, Cecilia, Manuel, Oriol, Morlin, Gregory, Rose, Suzanne J, Naqvi, Mariam, Goldfarb, Ilona T, DeZure, Adam, Telep, Laura, Tan, Susanna K, Zhao, Yang, Hahambis, Tom, Hindman, Jason, Chokkalingam, Anand P, Carter, Christoph, Das, Moupali, Osinusi, Anu O, Brainard, Diana M, Varughese, Tilly A, Kovalenko, Olga, Sims, Matthew D, Desai, Samit, Swamy, Geeta, Sheffield, Jeanne S, Zash, Rebecca, Short, William R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797739/
https://www.ncbi.nlm.nih.gov/pubmed/33031500
http://dx.doi.org/10.1093/cid/ciaa1466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797739/
https://www.ncbi.nlm.nih.gov/pubmed/33031500
http://dx.doi.org/10.1093/cid/ciaa1466

Ejemplares similares